Advanced Medical Solutions Group plc (LON:AMS - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 203.71 ($2.74) and traded as high as GBX 210.50 ($2.83). Advanced Medical Solutions Group shares last traded at GBX 208.50 ($2.80), with a volume of 929,118 shares trading hands.
Analysts Set New Price Targets
Separately, Berenberg Bank reaffirmed a "buy" rating and set a GBX 300 ($4.03) target price on shares of Advanced Medical Solutions Group in a research note on Wednesday, March 19th.
Read Our Latest Analysis on AMS
Advanced Medical Solutions Group Trading Up 0.5%
The firm's 50-day moving average price is GBX 197.35 and its 200 day moving average price is GBX 203.71. The company has a market cap of £448.05 million, a price-to-earnings ratio of 40.21, a P/E/G ratio of 5.00 and a beta of 0.74. The company has a current ratio of 8.39, a quick ratio of 4.58 and a debt-to-equity ratio of 37.01.
Advanced Medical Solutions Group (LON:AMS - Get Free Report) last issued its earnings results on Thursday, March 20th. The company reported GBX 10.65 ($0.14) earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a net margin of 8.49% and a return on equity of 4.57%. As a group, equities analysts expect that Advanced Medical Solutions Group plc will post 9.8159509 EPS for the current year.
Insider Activity
In other Advanced Medical Solutions Group news, insider A Christopher (Chris) Meredith sold 64,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of GBX 195 ($2.62), for a total value of £124,800 ($167,832.17). Also, insider Eddie Johnson sold 28,126 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The shares were sold at an average price of GBX 196 ($2.64), for a total value of £55,126.96 ($74,135.23). Over the last 90 days, insiders have sold 435,255 shares of company stock worth $84,691,330. Company insiders own 3.12% of the company's stock.
About Advanced Medical Solutions Group
(
Get Free Report)
AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®.
Further Reading
Before you consider Advanced Medical Solutions Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Advanced Medical Solutions Group wasn't on the list.
While Advanced Medical Solutions Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
